With $770K In Seed Funding, Playbasis Wants Businesses In Asia To Gamify


Intellectual Property and The Globalization of Big Pharma

The Invisible Opportunity: Hidden Truths Revealed

In Slashdot’s “Big Pharma Presses US To Quash Cheap Drug Production In India,” it states:

“Pharmaceutical Research and Manufacturers of America (PhRMA), are leaning on the United States government to discourage India from allowing the production and sale of affordable generic drugs to treat diseases such as cancer, diabetes, HIV/AIDS and hepatitis. India is currently on the U.S. government’s Priority Watch List — countries whose practices on protecting intellectual property Washington believes should be monitored closely. Last year Novartis lost a six-year legal battle after the Indian Supreme court ruled that small changes and improvements to the drug Glivec did not amount to innovation deserving of a patent. Western drugmakers Pfizer, GlaxoSmithKline, Novartis, Roche Holding, Sanofi, and others have a bigger share of the fast-growing drug market in India. But they have been frustrated by a series of decisions on patents and pricing, as part of New Delhi’s push to…

View original post 82 more words

India budget-2013/14 agri exports likely to touch $45 bln vs $41 bln in 2012/13 | Reuters

CHINDIA ALERT: You'll be living in their world, very soon

India’s Finance Minister P. Chidambaram told parliament on Monday that India’s 2013/14 agricultural exports were likely to touch $45 billion vs $41 billion in 2012/13.

Chidambaram was presenting an interim budget to tide public finances over until a new government is formed after elections due by May.

via India budget-2013/14 agri exports likely to touch $45 bln vs $41 bln in 2012/13 | Reuters.

Enhanced by Zemanta

View original post

A fine WordPress.com site